BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10092126)

  • 1. Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences.
    Cuthbert G; McCullough S; Finney R; Breese G; Bown N
    Genes Chromosomes Cancer; 1999 Apr; 24(4):295-8. PubMed ID: 10092126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias.
    von Bergh A; Emanuel B; van Zelderen-Bhola S; Smetsers T; van Soest R; Stul M; Vranckx H; Schuuring E; Hagemeijer A; Kluin P
    Genes Chromosomes Cancer; 2000 May; 28(1):14-22. PubMed ID: 10738298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
    Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
    Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cryptic MLL insertions using a commercial dual-color fluorescence in situ hybridization probe.
    Dyson MJ; Talley PJ; Reilly JT; Stevenson D; Parsons E; Tighe J
    Cancer Genet Cytogenet; 2003 Nov; 147(1):81-3. PubMed ID: 14580777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities.
    Mathew S; Behm F; Dalton J; Raimondi S
    Leukemia; 1999 Nov; 13(11):1713-20. PubMed ID: 10557043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation t(10;11) involving the MLL gene in acute myeloid leukemia. Importance of fluorescence in situ hybridization (FISH) analysis.
    Berger R; Le Coniat M; Flexor MA; Leblanc T
    Ann Genet; 1996; 39(3):147-51. PubMed ID: 8839887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the 11q23 region in acute myeloid leukemia.
    Avet-Loiseau H; Godon C; Li JY; Daviet A; Mellerin MP; Talmant P; Harousseau JL; Bataille R
    Genes Chromosomes Cancer; 1999 Oct; 26(2):166-70. PubMed ID: 10469455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias.
    Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A
    Haematologica; 2002 Oct; 87(10):1014-20. PubMed ID: 12368154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
    Fu JF; Hsu JJ; Tang TC; Shih LY
    Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings.
    Watanabe N; Kobayashi H; Ichiji O; Yoshida MA; Kikuta A; Komada Y; Sekine I; Ishida Y; Horiukoshi Y; Tsunematsu Y; Yano M; Nakadate H; Kaneko Y
    Leukemia; 2003 May; 17(5):876-82. PubMed ID: 12750700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
    Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature.
    Kim HJ; Ki CS; Park Q; Koo HH; Yoo KH; Kim EJ; Kim SH
    Genes Chromosomes Cancer; 2003 Sep; 38(1):8-12. PubMed ID: 12874781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.
    Fleischman EW; Reshmi S; Frenkel MA; Konovalova WI; Guleva GP; Kulagina OE; Konstantinova LN; Tupitsyn NN; Rowley JD
    Genes Chromosomes Cancer; 1999 Feb; 24(2):151-5. PubMed ID: 9885982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.